TOWER updates palletised container ahead of Covid vaccine

As the airfreight sector prepares for the anticipated widespread distribution of Covid-19 vaccines, cold chain solutions firm TOWER has launched a reusable palletised container that can store dry ice and maintain an internal temperature of less than -60°C.

The KTM42D has a double-door, lock-and-load system and external data logger, which enables the loading of two product-loaded pallets and the replenishing of dry ice in each container to be managed by two operatives in under five minutes without having to enter the container at any point.

TOWER said this means that industry-standard levels of health and safety, and minimal contact with dry-ice, as well as product storage below -60°C, can all be delivered “at a fraction of the cost” of running a deep freeze warehouse.

Richard Dudbridge, global sales manager at TOWER and one of the sponsors of the project, explained: “We were approached by several pharma and 3PL clients to solve the problem of keeping a palletised container at less than -60°C for 19 hours in transit and in storage at less than -60°C for 5 days.

“We’ve now tested two pallets at less than -60°C for 94 hours in transit and over 9 days in storage whilst still maintaining the airline compliance on dry-ice within a single container.”

Share this story

Related Topics

Latest pharma logistics news

New air cargo cover takes aim at cool dollies

By Damian Brett

A new cargo cover is being launched that aims to take on the thermal covers and cool dollies used to…

Read More

Share this story

Peli BioThermal expands ‘deep frozen’ range ahead of Covid-19 vaccine

By Rachelle Harry

Pharma container firm Peli BioThermal has expanded its ‘deep frozen’ product range to include solutions that can hold pharma products from -80…

Read More

Share this story

Air carriers begin transporting Covid-19 vaccines

By Rachelle Harry

Air carriers have already started transporting Covid-19 vaccines, ahead of widespread global distribution. The news comes as pharmaceutical firms Pfizer…

Read More

Share this story